European Research Infrastructures for Poverty Related Diseases (EURIPRED)

EURIPRED (European Research Infrastructures for Poverty Related Diseases) started in November 2013 and ended in October 2017. EURIPRED was a 4-year project that has received funding from the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 312661. EURIPRED has been co-funded with € 8.5 million by the European Commission.

EURIPRED is a collaborative infrastructure programme that has been working to reinforce the knowledge infrastructure across diseases. By encouraging collaboration and information sharing, EURIPRED was able to speed the development of new tools (vaccines, drugs, microbicides) to combat Tuberculosis, HIV, Malaria, Hepatitis B and Hepatitis C. Scientists from 17 research partners in 10 countries have been collaborating in this programme. One of the key activities since the beginning of the project has to been to providing reference reagents, services and trainings for free

Read the project in one page.

The figure below sums up the TNA activities in the EURIPRED project:



Our research partners

EURIPRED comprises a team of 17 globally leading organisations in the field of poverty related diseases. Read more>>

Free Services

Free reference reagents and other services are available for poverty related diseases.